E. Bemi, E. Pizza, L. Lattanzi, G. Perugi - Vol. 5/1
Testo Immagini Bibliografia Summary Riassunto Indice
Depressione atipica, spettro bipolare e disturbo borderline
di personalità
Atypical depression, bipolar spectrum and Borderline Personality Disorder
1 West ED, Dally PJ.
Effect of iproniazid in depressive syndromes.
British Medical Journal 1959;1:1491-1494.
2 Sargant W, Dally PJ.
The treatment of anxiety states and atypical depressions by the monoamine
oxidase inhibitor.
Journal of Neuropsychology 1962;3(suppl 1):96-103. s
3 Sovner RD.
The clinical characteristics and treatment of atypical depression.
Journal of Clinical Psychiatry 1981;42:7.
4 Thase ME.
Atypical depressions.
In: Flach F, ed. Diagnostics and psychopathology. New York: Norton
1987:83-96.
5 Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison
W, Rabkin J, Tricamo E, Markowitz JS, Klein DF.
Phenelzine vs imipramine in atypical depression: A preliminary report.
Archives of General Psychiatry 1984;41:669-677.
6 Paykel ES, Rowan PR, Parker RR, Bhat AV.
Response to phenelzine and amitriptyline in subtypes of outpatient
depression.
Archives of General Psychiatry 1982;39:1041-1049.
7 Ravaris CL, Robinson DS, Ives JO, Nies A, Bartlett D.
Phenelzine and amitriptyline in the treatment of depression: A comparison
of present and past studies.
Archives of General Psychiatry 1980;37:1075-1980.
8 Quitkin FM, Stewart JW, Mc Grath PJ, Tricamo E., Rabkin
JG, Ocepek-Welikson K, Nunes E, Harrison W e Klein DF.
Columbia Atypical Depression. A subgroup of depressives with better response
to MA0I than to tricyclic antidepressant or placebo.
British Journal of Psychiatry 1993;163(suppl 21):30-34.
9 Lonnqvist J, Sihvo S, Syvalahti E, Kivirusu O.
Moclobemide and Fluoxetine in Atypical Depression: a double-blind trial.
Journal of Affective Disorders 1994; 32:169-177.
10 Van Prag HM.
Diagnosis, the rate-limiting factor of biological depression research.
Neuropsychobiology 1993;28197-206.
11 Perugi G, Akiskal HS. Lattanzi L, Bemi E, Cecconi D, Mastrocinque
C, Patronelli A, Vignoli S.
The high prevalence of soft bipolar (II) features in atypical depression.
Comprehensive Psychiatry 1998;39:1-9.
12 American Psychiatric Association.
Diagnostic and Statistical Manual of Mental Disorders. DSM IV.
4th edition. Washington, DC: American Psychiatric Association 1994.
13 ICD 10.
Classification of Mental and Behavioural Disorders-WHO.
Genève 1992.
14 Yerevanian S, Akiskal H.
Neurotic, Characterological and Olysthimic Depression.
Psychiatric Clinic of North America 1979;2:595-617.
15 Davidson JRT, Miller RD, Turnbull CD, Sullivan JL.
Atypical depression.
Archives of General Psychiatry 1982;39:527-534.
16 Liebowitz MR, Klein DF.
Hysteroid disphoria.
Psychiatric Clinics of North America 1979;2:555-575.
17 Himmelhoc JM, Thase ME.
The vagaries of the concept of atypical depression.
In: Howells JG, eds. Modern Perspectives in the Psychiatry of the Affective
Disorders. New York: Plenum Press 1989:223-242.
18 Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison
WM, Markowiz JS, Rabkin JG, Tricamo E, Goetz DM, Klein DF.
Antidepressant specificity in atypical depression.
Archives of General Psychiatry 1988;45:129-137.
19 Akiskal HS.
Mood Disorders: clinical features.
In: Kaplan HI, Sadock BJ, eds. Comprehesive textbook of psychiatry/IV.
Vol. 1. Baltimore: Williams & Wilkins 1995;Vol.2:1024-1027.
20 Akiskal HA, Mallya A.
Criteria for the soft bipolar spectrum: treatment implication.
Psychopharmacology Bullettin 1987;26:68-73.
21 Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W,
Keller M, e Coll.
Switching from "unipolar" to bipolar II. An 11 year prospective
study of clinical and temperamental predictor in 559 patients.
Archives of General Psychiatry 1995;52:114-123.
22 Akiskal HS.
Subaffective disorders: dysthymic, cyclothymic and bipolar II disorders in
the "borderline" realm.
Psychiatric Clinics of North America 1981;4:25-46.
23 Klein DF.
Psychopharmacological treatment and delineation of Borderline disorder.
In: Hartocollis P, ed. Borderline Personality Disorders. New York:
International Universities Press 1977:365-383.
24 Soloff PH, Anselm G, Swami N, Schultz PM.
Characterizing depression in Borderline Patients.
Journal of Clinical Psychiatry 1987;48:155-157.
25 Elliott GR, Gunderson JG.
Affective and Borderline Personality Disorder.
In: Georgotas A, Cancro R, eds. Depression and Mania. A Comprehensive
Textbook. New YorK: Elsevier 1988:130-147.
26 Parsons B, Frederic M, Quitkin FM, McGrath PJ, Jonathan
W, Stewart JW, Tricamo E, Ocepeck-Welikson K, Harrison W, Rabkin J, Wager
G, Nunes E.
Phenelzine, imipramine, and placebo in borderline patients meeting criteria
for atypical depression.
Psychopharmacology Bullettin 1989;V:524-534.
27 Soloff PH, Cornelius J, George A, Nathan S, Paul J, Ulrich
R.
Efficacy of phenelzine and haloperidol in borderline personality disorder.
Archives of General Psychiatry 1993;50:377-385.
28 Norden MJ.
Fluoxetine in Borderline personality disorders
Progress in Neuro-Psychopharmacology and Biological Psychiatry 1986;13:885-893.
29 Cornelius JR, Soloff PH, Perel JM, Ulrich RF.
Fluoxetine trial in borderline personality disorder.
Psychopharmacology Bullettin 1990;26:49-152.
31 Markowitz PS, Calabrese JR, Schultz SC, Meltzer HI.
Fluoxetine in borderline and schizotypal personality disorder.
Presented at the Society of Biological Psychiatry 45th Annual Meeting
12, 1990; New York, N.Y.
32 Liebowitz MR, Klein DF.
Interrelationship of histeroid dysphoria and borderline personality disorder.
Psychiatric Clinics of North America 1981;4:67-87.
32 Quitkin FM, Harrison MDW, Liebowitz M, McGrath P, Rabkin
JG, Stewart J, Markowitz J.
Defining the boundaries of atypical depression.
Journal of Clinical Psychiatry 1984;45:19-21.
33 Cassano GB, Musetti L, Perugi G, Soriani A, Mignani V,
McNair DM, Akiskal HS.
A proposed new approach to the clinical subclassification of depression
illness.
Pharmacopsychiatry 1988;21:19-23.
34 Stewart JW, McGrath PJ, Rabkin JG, Quitkin FM.
Atypical depression. A valid clinical entity?
Psychiatric Clinics of North America 1993;16:479-495.
35 Spitzer RL, Williams JBW.
Structured Clinical Interview for DSM-III-R, Upjohn version Revised (SCID-UP-R).
New York: New York State Psychiatric Institute 1988.
36 American Psychiatric Association.
Diagnostic and Statistical Manual of Mental Disorders.
DSM III-R. Washington, DC: American Psychiatric Association 1987.
37 Derogatis LR, Lipman RS, Covi L.
The HSCL-90: An outpatient psychiatric rating scale.
Psychopharmacology Bullettin 1973;9:13-28.
38 Hamilton M.
Development of a rating scale for primary depressive illness.
British Journal of Social Clinical Psychology 1967;6:278-296.
39 Rosenthal NE, Heffernan M M.
Bulimia, carbohydrate craving, and depression. A central connection?
In: Wurtman RJ, ed. Nutrition and the brain. Vol. 7. New York: Raven
Press 1986:139-166.
40 McGrath PJ, Stewart JW, Harrison WM, Ocepek-Welikson K,
Rabkin JG, Nunes EN, Wager SG, Tricamo E, Quitkin FM, Klein DF.
The predictive value of symptoms of atypical depression for differential
drug treatment outcome.
Journal of Clinical Psychopharmacology 1992;12:197-202.
41 Musetti L, Perugi G, Soriani A, Cassano GB.
Disturbi bipolari.
In: Pancheri P, Cassano GB, eds. Trattato Italiano di Psichiatria.
Milano: Masson 1992;50:1633-1638.
42 Fieve RR, Dunner DJ.
Unipolar and Bipolar affective states.
In: Flach F, Draghi FS, eds. The nature and treatment of depression.
New York: John Wiley and Sons 1975.
43 Cassano GB, Akiskal HS, et al.
Psychopathology, temperament, and past course in primary major depression.
toward a redefinition of bipolarity with a new semistructured interview for
a depression.
Psychopathology 1989;22:278-288.
44 Stewart JW, McGrath PJ, Quitkin FM, Harrison W, Markovitz
J, Wager S, Liebowitz MR.
Relevance of DSM-III Depressive subtype and chronicity of antidepressant
efficacy in atypical depression.
Archives of General Psychiatry 1989;46:1080-1087.
45 Quitkin FM, McGrath PJ, Stewart JW, Harrison WM, Tricamo
E, Wager SG,Welikson KO, Nunes E, Rabkin JG, Klein DF.
Atypical depression, panic attacks, and response to imipramine and phenelzine.
A replication.
Archives of General Psychiatry 1990;47:935-941.
46 Spitzer RL, Endicott J, Robins E.
Research Diagnostic Criteria: rationale and reliability.
Archives of General Psychiatry 1978;35:773-782.
47 Berkson J.
Limitations of the application of fourfold table analysis to hospital data.
Biomedical Bullettin 1946;2:47-53.
48 Leckman JF, Weissman MN, Merikangas KR, Pauls DL, Prusoff
BA.
Panic disorder and major depression: increased risk of depression, alcoholism,
panic and phobic disorders in families of depressed patients with panic disorder.
Archives of General Psychiatry 1983;40:1055-1067.
49 Akiskal HS, Lemmi H, Dickson H, et al.
Chronic Depressions: Part 2. Sleep EEG differentiation of primary dysthymic
disorders from anxious depressions.
Journal of Affective Disorders 1984;6:287-295.
50 Akiskal HA, Lemmi H.
Sleep EEG findings bearing on the relationship of anxiety and depressive
disorders.
In: Racagni G, Smeraldi E, eds. Anxious Depressions: Assessment and Treatment.
New York: Raven Press 1987:153-159.
51 Beard G.
A Practical Treatise on Nervous Exhaustion (Neurasthenia): Its Nature,
Sequences and Treatment.
New York: Wood 1880.
52 Davidson J, Zisook S, Giller E, Helms M.
Symptoms of interpersonal sensitivity in depression.
Comprehensive Psychiatry 1989;30:357-368.
53 Liebowitz MR.
Atypical depression: Serotoninergic or dopaminergic?
In: Cassano GB, Akiskal HA, eds. Serotonin-related psychiatric syndromes:
clinical and therapeutic links. London: Royal Society of Medicine Services
Limited 1991.
54 Kramer PD.
Listening to Prozac.
New York: Penguin Books 1991.
55 Sargant W.
Drugs in the treatment of depression.
British Medical Journal 1961;1:225-227.
56 Davidson JRT, Giller EL, Zisook S, Overall JE.
An efficacy study of isocarbossazid and Placebo in depression, and its
relationship to depressive nosology.
Archives of General Psychiatry 1988;45:120-127.
57 Coryell W, Endicott J, Reich T, Andreasen N, Keller M.
A family study of bipolar II disorder.
British Journal of Psychiatry 1984;145:49-54.
58 Endicott J, Nee J, Andreasen N.
Bipolar II: combine or keep separate?
Journal of Affective Disorders 1985;8:17-28.
59 Akiskal HS, Haykal RF.
Dysthimic, "Atypical", and Residual Depressive Disorders.
In: Georgotas A, Cancro R, eds. Depression and Mania: A Comprehensive
Textbook. New York: Elsevier 1988;96-103.
60 Simpson SG, Al-Mufti R, Andersen AE, DePaulo JR.
Bipolar II affective disorder in eating disorder inpatients.
Journal of Mental and Nervous Disorders 1992;180:719-722.
61 DePaulo JR, Simpson SG
Therapeutic and genetic prospects of an atypical affective disorder.
Journal of Clinical Psychopharmacology 1987;7:50S-54S.
62 Swift WJ, Andrews D, Barklage NE.
The relationship between affective disorder and eating disorders: a review
of the literature.
American Journal of Psychiatry 1986;143:290-299.
63 De Leo D, Pavan L.
I comportamenti suicidari.
In: Pancheri P, Cassano GB, eds. Trattato Italiano di Psichiatria.
Milano: Masson 1992:1633-1638.
64 Perugi G, Ramacciotti S, Nassini S, Toni C, Milanfranchi
A, Musetti L, Akiskal HS.
The comorbidity of anxiety and mood disorders: a re-examination based on
a systematic study of 269 patients with panic, social phobic and obsessive-compulsive
disorders.
Journal of Psychiatric Research (in press).
65 Perugi G, Toni C, Benedetti A, Simonetti B, Simoncini
M, Torti C, Musetti L, Akiskal HS.
Delineating a putative phobic-anxious temperament in 126 panic-agoraphobic
patients: toward a reapproachement of European and US views.
Journal of Affective Disorders 1998;47:11-23.